D-1568-2014 Class I Terminated

Recalled by Pharmakon Pharmaceuticals — Noblesville, IN

FDA drug recall D-1568-2014 was initiated by Pharmakon Pharmaceuticals on Apr 21, 2014 and is designated Class I. Reason for recall: Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. The recall status is terminated (terminated Dec 3, 2014). Affected quantity: 5 Syringes.

Recall Details

Product Type
Drugs
Report Date
Sep 3, 2014
Initiation Date
Apr 21, 2014
Termination Date
Dec 3, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 Syringes

Product Description

Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.

Reason for Recall

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

Distribution Pattern

United States: TX, IL, MD, IN

Code Information

Lot #: E0333282R; Exp: 7/13/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1568-2014
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.